Author

Faraha Ahmed

Observed name: Ahmed, Faraha

Institution: Jamia Hamdard

Observed institution: Jamia Hamdard

ORCID: 0000-0001-5438-0350

Observed ORCID: 0000-0001-5438-0350

OpenAlex ID: A5081860334

Immunology of Osteoporosis: Relevance of Inflammatory Targets for the Development of Novel Interventions

2022 · Syed Sufian Ahmad, Faraha Ahmed, et al. · Immunotherapy · 25

Utilization of Nanotechnology to Improve Bone Health in Osteoporosis Exploiting Nigella sativa and Its Active Constituent Thymoquinone

2022 · Javed Ahmad, Hassan A. Albarqi, et al. · Bioengineering · 12

PDF

Recent Advances in Theranostic Applications of Nanomaterials in Cancer

2021 · Faraha Ahmed, Mohammad Ahmed Khan, et al. · Current Pharmaceutical Design · 10

Tauopathy in AD: Therapeutic Potential of MARK-4

2024 · Mumtaz, Faraha Ahmed, et al. · Current Alzheimer Research · 6

Phytochemicals and Nanotechnology: A Powerful Combination against Breast Cancer

2024 · Sadat Shafi, Faraha Ahmed, et al. · Mini-Reviews in Medicinal Chemistry · 6

Unravelling the role of dipeptidyl peptidases-8/9 (DPP-8/9) in inflammatory osteoporosis: a comprehensive study investigating chrysin as a potential anti-osteoporotic agent

2024 · Syed Sufian Ahmad, Faraha Ahmed, et al. · Journal of Pharmacy and Pharmacology · 6

PDF

Mechanistic insights toward progress in alogliptin beyond glycemic control: translational perspective

2025 · Faraha Ahmed, Syed Sufian Ahmad, et al. · Beni-Suef University Journal of Basic and Applied Sciences · 5

PDF

Targeting dipeptidyl peptidase-8/9 to combat inflammation-induced osteoclastogenesis in RAW264.7 macrophages and analysis of anti-osteoclastogenesis potential of chrysin.

2025 · Syed Sufian Ahmad, Faraha Ahmed, et al. · PubMed Central · 4

PDF

Osteogenic effect of alogliptin in chemical-induced bone loss: a tri-modal in silico, in vitro, and in vivo analysis

2024 · Faraha Ahmed, Syed Sufian Ahmad, et al. · Journal of Pharmacy and Pharmacology · 4

PDF

Hyperglycaemia induced osteoporosis: Is there a hope with dipeptidyl peptidase-4 inhibitors?

2023 · Faraha Ahmed, Syed Sufian Ahmad, et al. · Health Sciences Review · 4

Regulatory affairs in clinical trials

2021 · Mohammad Ahmed Khan, Sadat Shafi, et al. · Elsevier eBooks · 2

Proteases and Osteoporosis: A Comprehensive Review of Their Role in Bone Health

2025 · Syed Sufian Ahmad, Faraha Ahmed, et al. · Current Drug Targets · 1

Theranostic Approaches for Diagnosis and Treatment of Cancer: An Update

2023 · Ruhi Ali, Faraha Ahmed, et al. · Biological and medical physics, biomedical engineering · 1

Current Status of Senolytics and Senomorphics: Mechanistic Insights, Clinical Progress, and Future Directions

2026 · Faraha Ahmed, Pinki Mishra, et al. · Preprints.org

Alogliptin-metformin synergy ameliorates diabetes-associated bone loss via modulation of DPP-4 activity and OPG/RANKL signaling

2026 · Tufail Ahmad, Syed Sufian Ahmad, et al. · 3 Biotech

Senolytics in Skin Care and Skin Diseases

2026 · Syed Sufian Ahmad, Faraha Ahmed · CRC Press eBooks

Senotherapeutics in Neurological Disorders

2026 · Faraha Ahmed, Razia Khanam · CRC Press eBooks

Development, synthesis and preclinical evaluation of naringenin and its semi-synthetic derivatives in postmenopausal osteoporosis

2025 · Shaheen Jabbar, Faraha Ahmed, et al. · Natural Product Research

Osteoporosis and Sympathetic Nerve Activity: A Review

2025 · Faraha Ahmed, Syed Sufian Ahmad, et al. · Research Journal of Pharmacy and Technology

Modulation of Bone Turnover Markers with Dipeptidyl Deptidase-4: Interplay in Bone Health

2025 · Faraha Ahmed, Syed Sufian Ahmad, et al. · Current Drug Therapy

Senolytics in Brain Disorders: A Novel Pharmacological Approach to Control Cellular Senescence and Oxidative Stress

2023 · Faraha Ahmed, Razia Khanam · Springer eBooks

Works count: 23

Citation count: 86

H-index: 6

I10-index: 3